Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why DexCom Stock Flopped on Friday


The stock of highly specialized healthcare company (NASDAQ: DXCM) wasn't the picture of health on Friday. It lost nearly 2% of its value in that day's trading session, on the back of an earnings release that raised investor concerns about slowing sales growth. The S 500 index outperformed the stock, and that's not saying much, as it essentially ended the day flat over Thursday.

Reporting its third-quarter results after market hours Thursday, DexCom said its revenue amounted to $994 million for the period. This was, however, only 2% higher on a year-over-year basis for the previously fast-growing glucose monitoring products specialist. Non-GAAP (adjusted) net income fell to slightly over $181 million ($0.45 per share) from the year-ago figure of $204 million.

According to Zack's, the consensus analyst estimate for profitability was $0.43. Meanwhile, DexCom only marginally topped the average prognosticator projection for revenue.

Continue reading


Source Fool.com

Dexcom Inc. Stock

€76.32
1.460%
There is an upward development for Dexcom Inc. compared to yesterday, with an increase of €1.10 (1.460%).
With 27 Buy predictions and not a single Sell prediction Dexcom Inc. is an absolute favorite of our community.
As a result the target price of 89 € shows a slightly positive potential of 16.61% compared to the current price of 76.32 € for Dexcom Inc..
Like: 0
Share

Comments